SEATTLE GUMMY COMPANY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2016-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://seattlegummy.com/
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2024-06-13
- Lead Sponsor
- Seattle Gummy Company
- Target Recruit Count
- 30
- Registration Number
- NCT04762082
Relative Bioavailability Study to Evaluate Cetirizine HCl Gummy 10 mg and Cetirizine HCl Oral Tablets 10 mg
Phase 1
Not yet recruiting
- Conditions
- Allergy
- Interventions
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2024-06-13
- Lead Sponsor
- Seattle Gummy Company
- Target Recruit Count
- 30
- Registration Number
- NCT04071821
News
Gummy Drug Delivery Systems Show Promise for Patient Compliance, Face Manufacturing Challenges
Gummies have emerged as the second-best selling delivery format in the vitamins and supplements market, showing potential for pharmaceutical applications to improve patient compliance.